文献速递淋巴瘤

血管免疫母细胞性T细胞淋巴瘤认识进展

Advances in understanding of angioimmunoblastic T-cell lymphoma.
PubMed 文献 · Leukemia · 2020-07-23

血管免疫母细胞性T细胞淋巴瘤(AITL)自20世纪70年代初被认识已近半个世纪,其理解因多项发现而显著改变。AITL的关键特征之一是异常免疫活动,目前既被视为肿瘤性疾病又被视为炎症性疾病。本文综述AITL认识的最新进展,聚焦尚未解决的问题。

要点

  • AITL的关键特征之一是异常免疫活动。
  • AITL目前既被视为肿瘤性疾病又被视为炎症性疾病。
  • 本文综述AITL认识进展,聚焦尚未解决的问题。

核心结论

  • 对AITL在细胞和遗传层面的理解越深入,越将其视为既是肿瘤性疾病又是炎症性疾病。

研究设计与样本

  • 综述,聚焦AITL认识的最新进展及尚未解决的问题。

主要发现

  • AITL自20世纪70年代初被认识已近半个世纪,对其理解因多项发现和见解而显著改变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It has been nearly half a century since angioimmunoblastic T-cell lymphoma (AITL) was characterized in the early 1970's. Our understanding of the disease has dramatically changed due to multiple discoveries and insights. One of the key features of AITL is aberrant immune activity. Although AITL is now understood to be a neoplastic disease, pathologists appreciated that it was an inflammatory condition. The more we understand AITL at cellular and genetic levels, the more we view it as both a neoplastic and an inflammatory disease. Here, we review recent progress in our understanding of AITL, focusing on as yet unsolved questions.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Chiba S, Sakata-Yanagimoto M. Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia. 2020. PMID: 32704161. doi:10.1038/s41375-020-0990-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。